Mimedx Group, Inc2024财年第二财季实现净利润17.62百万美元，同比增加1368.33%

自选股智能写手08-04

8月4日，Mimedx Group, Inc（MDXG.US）公布财报，公告显示公司2024财年第二财季净利润为17.62百万美元，同比增加1368.33%；其中营业收入为87.21百万美元，同比增加7.32%，每股基本收益为0.12美元。从资产负债表来看，Mimedx Group, Inc（MDXG.US）总负债62.14百万美元，其中短期债务1000000.00美元，资产负债比为0.04，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2456376221?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-04 00:16","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2456376221","market":"us","top_or_hot":-1,"title":"Mimedx Group, Inc2024财年第二财季实现净利润17.62百万美元，同比增加1368.33%","media":"自选股智能写手","content":"<div>\n<p>8月4日，Mimedx Group, Inc（MDXG.US）公布财报，公告显示公司2024财年第二财季净利润为17.62百万美元，同比增加1368.33%；其中营业收入为87.21百万美元，同比增加7.32%，每股基本收益为0.12美元。从资产负债表来看，Mimedx Group, Inc（MDXG.US）总负债62.14百万美元，其中短期债务1000000.00美元，资产负债比为0.04，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240804001702957ab1ca&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mimedx Group, Inc2024财年第二财季实现净利润17.62百万美元，同比增加1368.33%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMimedx Group, Inc2024财年第二财季实现净利润17.62百万美元，同比增加1368.33%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-04 00:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240804001702957ab1ca&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月4日，Mimedx Group, Inc（MDXG.US）公布财报，公告显示公司2024财年第二财季净利润为17.62百万美元，同比增加1368.33%；其中营业收入为87.21百万美元，同比增加7.32%，每股基本收益为0.12美元。从资产负债表来看，Mimedx Group, Inc（MDXG.US）总负债62.14百万美元，其中短期债务1000000.00美元，资产负债比为0.04，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240804001702957ab1ca&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDXG","symbol_name":"MiMedx Group, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240804001702957ab1ca&s=b","article_id":"2456376221","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240804001702957ab1ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2456376221","pubTimestamp":1722701815,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"8月4日，Mimedx Group, Inc公布财报，公告显示公司2024财年第二财季净利润为17.62百万美元，同比增加1368.33%；其中营业收入为87.21百万美元，同比增加7.32%，每股基本收益为0.12美元。从资产负债表来看，Mimedx Group, Inc总负债62.14百万美元，其中短期债务1000000.00美元，资产负债比为0.04，流动比率为0.04。机构评级：截至2024年8月4日，当前有6家机构对Mimedx Group, Inc目标价做出预测，其中目标均价为12.00美元，其中最低目标价为11.00美元，最高目标价为14.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"MDXG":"MiMedx Group, Inc."},"translate_title":"Mimedx Group, Inc achieved net profit of US $17.62 million in the second fiscal quarter of fiscal year 2024, a year-on-year increase of 1368.33%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDXG":0.9},"content_text":"8月4日，Mimedx Group, Inc（MDXG.US）公布财报，公告显示公司2024财年第二财季净利润为17.62百万美元，同比增加1368.33%；其中营业收入为87.21百万美元，同比增加7.32%，每股基本收益为0.12美元。从资产负债表来看，Mimedx Group, Inc（MDXG.US）总负债62.14百万美元，其中短期债务1000000.00美元，资产负债比为0.04，流动比率为0.04。机构评级：截至2024年8月4日，当前有6家机构对Mimedx Group, Inc目标价做出预测，其中目标均价为12.00美元，其中最低目标价为11.00美元，最高目标价为14.00美元。公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。其产品主要面向伤口护理、烧伤、外科、运动医学和骨科市场。MiMedx的主要产品是由羊膜组织加工的同种异体移植物，包括外用的EpiFix和内用的AmnioFix。AmnioCord, AmnioFill, EpiBurn和EpiCord是其其他一些产品。此外，它还通过许可向第三方销售用于眼科手术和牙科应用的同种异体移植物。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2456376221"}